Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype
- PMID: 15753379
- DOI: 10.1158/0008-5472.CAN-04-3609
Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype
Abstract
Src kinase has long been recognized as a factor in the progression of colorectal cancer and seems to play a specific role in the development of the metastatic phenotype. In spite of numerous studies conducted to elucidate the exact role of Src in cancer progression, downstream targets of Src remain poorly understood. Gene expression profiling has permitted the identification of large sets of genes that may be functionally interrelated but it is often unclear as to which molecular pathways they belong. Here we have developed an iterative approach to experimentally reconstruct a network of gene activity regulated by Src and contributing to the invasive phenotype. Our strategy uses a combination of phenotypic anchoring of gene expression profiles and loss-of-function screening by way of RNA-mediated interference. Using a panel of human colon cancer cell lines exhibiting differential Src-specific activity and invasivity, we identify the first two levels of gene transcription responsible for the invasive phenotype, where first-tier genes are controlled by Src activity and the second-tier genes are under the influence of the first tier. Specifically, perturbation of first-tier gene activity by either pharmacologic inhibition of Src or RNA-mediated interference-directed knockdown leads to a loss of invasivity and decline of second-tier gene activity. The targeting of first-tier genes may be bypassed altogether because knockdown of second-tier genes led to a similar loss of invasive potential. In this manner, numerous members of a "transcriptional cascade" pathway for metastatic activity have been identified and functionally validated.
Similar articles
-
Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.Chin J Dig Dis. 2006;7(2):97-102. doi: 10.1111/j.1443-9573.2006.00254.x. Chin J Dig Dis. 2006. PMID: 16643337
-
Identification of Src transformation fingerprint in human colon cancer.Oncogene. 2002 Oct 17;21(47):7256-65. doi: 10.1038/sj.onc.1205900. Oncogene. 2002. PMID: 12370817
-
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.Cancer Res. 2010 Jun 1;70(11):4644-54. doi: 10.1158/0008-5472.CAN-09-3828. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460542
-
Role of Src expression and activation in human cancer.Oncogene. 2000 Nov 20;19(49):5636-42. doi: 10.1038/sj.onc.1203912. Oncogene. 2000. PMID: 11114744 Review.
-
[Molecular mechanism of tumor progression. From Krompecher to the DNA microarray].Magy Onkol. 2004;48(1):3-11. Epub 2004 Apr 23. Magy Onkol. 2004. PMID: 15105890 Review. Hungarian.
Cited by
-
Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.Cancer Biol Ther. 2016;17(3):262-71. doi: 10.1080/15384047.2016.1139240. Epub 2016 Jan 19. Cancer Biol Ther. 2016. PMID: 26785864 Free PMC article.
-
PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.Pharmacol Ther. 2009 Jan;121(1):14-9. doi: 10.1016/j.pharmthera.2008.09.006. Epub 2008 Nov 1. Pharmacol Ther. 2009. PMID: 18992768 Free PMC article. Review.
-
A factor graph nested effects model to identify networks from genetic perturbations.PLoS Comput Biol. 2009 Jan;5(1):e1000274. doi: 10.1371/journal.pcbi.1000274. Epub 2009 Jan 30. PLoS Comput Biol. 2009. PMID: 19180177 Free PMC article.
-
Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion.Cancer Res. 2010 Sep 1;70(17):6957-67. doi: 10.1158/0008-5472.CAN-10-1169. Epub 2010 Jul 22. Cancer Res. 2010. PMID: 20651255 Free PMC article.
-
Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.Mol Cancer. 2010 Apr 30;9:98. doi: 10.1186/1476-4598-9-98. Mol Cancer. 2010. PMID: 20433755 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous